Benzinga | Aug 5, 2020 04:09PM EDT

Sangamo Therapeutics Q2 EPS $(0.26), Same YoY, Sales $21.55M Up From $17.55M YoY

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.26) per share. This is unchanged from the same period last year. The company reported $21.55 million in sales this quarter. This is a 22.82 percent increase over sales of $17.55 million the same period last year.